Advertisement

Reactions Weekly

, Volume 1748, Issue 1, pp 149–149 | Cite as

Crizotinib/erlotinib/gefitinib

Elevated liver aminotransferase and nausea: 3 case reports
Case report
  • 13 Downloads

Reference

  1. Wang W, et al. Crizotinib with or without an EGFR-TKI in treating EGFR-mutant NSCLC patients with acquired MET amplification after failure of EGFR-TKI therapy: A multicenter retrospective study. Journal of Translational Medicine 17: 52, No. 1, 21 Feb 2019. Available from: URL: http://doi.org/10.1186/s12967-019-1803-9 - China

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations